GlioCART logo

GlioCART jobs and careers

About GlioCART

GlioCART is a University of Basel spin-off focused on translating a dual-action CAR-T therapy for glioblastoma into clinical application by combining tumor targeting with immune microenvironment reprogramming. Our mission is to achieve durable clinical benefit for patients with glioblastoma.

Employees
1 to 10

Leadership

The top of GlioCART's org chart, with how many people report into each leader.

DW

Dieter Willmann

Co-Founder & CEO (2025 to present)

Jobs at GlioCART

No open positions right now. Explore more companies on TheJobsMap.